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Mapping the proteome of Leishmania Viannia parasites using
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In this study we have demonstrated the potential of two-dimensional electrophoresis (2DE)-
based technologies as tools for characterization of the Leishmania proteome (the expressed
protein complement of the genome). Standardized neutral range (pH 5-7) proteome maps of
Leishmania (Viannia) guyanensis and Leishmania (Viannia) panamensis promastigotes were
reproducibly generated by 2DE of soluble parasite extracts, which were prepared using lysis
buffer containing urea and nonidet P-40 detergent. The Coomassie blue and silver nitrate
staining systems both yielded good resolution and representation of protein spots, enabling
the detection of approximately 800 and 1,500 distinct proteins, respectively. Several reference
protein spots common to the proteomes of all parasite species/strains studied were isolated
and identified by peptide mass spectrometry (LC-ES-MS/MS), and bioinformatics approaches
as members of the heat shock protein family, ribosomal protein S12, kinetoplast membrane
protein 11 and a hypothetical Leishmania-specific 13 kDa protein of unknown function.
Immunoblotting of Leishmania protein maps using a monoclonal antibody resulted in the specific
detection of the 81.4 kDa and 77.5 kDa subunits of paraflagellar rod proteins 1 and 2, respectively.
Moreover, differences in protein expression profiles between distinct parasite clones were
reproducibly detected through comparative proteome analyses of paired maps using image
analysis software. These data illustrate the resolving power of 2DE-based proteome analysis.
The production and basic characterization of good quality Leishmania proteome maps provides
an essential first step towards comparative protein expression studies aimed at identifying the
molecular determinants of parasite drug resistance and virulence, as well as discovering new
drug and vaccine targets.
Key words: proteomics, proteome, Leishmania, two-dimensional polyacrylamide gel
electrophoresis.
Mapa del proteoma de parásitos de Leishmania Viannia a partir de electroforesis de geles
de poliacramida en dos dimensiones y otras técnicas asociadas
En este estudio demostramos el potencial de la electroforesis en dos dimensiones (2DE) como
herramienta para la caracterización del proteoma de Leishmania (expresión proteica
complementaria del genoma). Los proteomas por 2DE en el rango neutro (pH 5-7) de extractos
solubles de promastigotes de Leishmania (Viannia) guyanensis y Leishmania (Viannia)
panamensis fueron reproducibles usando tampón de lisis de urea y nonidet P-40. Con la
tinción de azul de Coomassie y nitrato de plata se detectaron, con buena resolución, 800 y
1.500 puntos de proteínas, respectivamente. Entre las proteínas de referencia comunes, aisladas
de los proteomas de las cepas estudiadas, se identificaron por medio de espectrometría de
masa de péptidos (LC-ES-MS/MS) y métodos bioinformáticos, proteínas de choque térmico,
proteína ribosomal S12, proteína de membrana del cinetoplasto 11 y una proteína hipotética
específica de Leishmania de 13 kDa con función desconocida. Por inmunoblot y utilizando un
anticuerpo monoclonal, se detectaron específicamente las proteínas paraflagelar 1 y 2 de 81,4
kDa y 77,5 kDa, respectivamente. La expresión proteica diferencial encontrada en los distintos
clones de parásitos fueron reproducibles al ser comparados por medio de un programa
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analizador de imágenes. Estos datos demuestran el poder de resolución del análisis de
proteomas por 2DE. La producción y caracterización de mapas proteicos básicos de Leishmania
con buena calidad constituye un paso esencial en los estudios proteómicos comparativos
orientados a la identificación de factores moleculares involucrados en la resistencia a drogas,
virulencia de parásitos y el descubrimiento de blancos para nuevas drogas y vacunas.
Palabras clave: proteómica, proteoma, Leishmania, electroforesis de geles de poliacrilamida
en dos dimensiones.
Proteomics examines the dynamics of cellular
protein synthesis, and provides a novel approach
to studies of gene expression and protein function
that complements genomic information. Direct
profiling and characterization of the proteome (all
of the proteins produced from the genetic
information of a cell) is advantageous since
proteins are both the functional cellular
components that determine biological phenotype
and the targets of most therapeutic agents (1,2).
Proteomics has the unique capacity to resolve
and identify multiple protein forms produced from
a single gene by mRNA processing and/or post-
translational modifications (e.g., glycosylation,
phosphorylation), which are critical in modulating
protein function (2,3); these mechanisms generate
a diversity of protein forms and functions that
cannot be predicted by genomic analysis alone.
By facilitating comparative analyses of protein
expression profiles in cells of different genetic,
physiological and developmental backgrounds,
proteomics has multiple applications in infectious
diseases research (1,2).
In the case of Leishmania, the protozoan parasite
that gives rise to the cutaneous, mucocutaneous
and visceral forms of leishmaniasis currently
affecting 12-15 million people worldwide (4,5),
proteomics has high potential as a tool for
identifying the molecular determinants of parasite
drug resistance and virulence, and for the
discovery of new therapeutic targets.
The key technical aspects of experimental
proteomics are the solubilization, separation and
detection of proteins via two-dimensional
polyacrylamide gel electrophoresis (2DE) and
staining, examination of the resulting proteome
maps using advanced image analysis software,
and the identification of individual proteins
principally by biological mass spectrometry
coupled with bioinformatics tools.
The objective of this study is to demonstrate the
use of 2DE-based technologies in the construction
and partial characterization of reference proteome
maps of parasites of the Leishmania (Viannia)
subgenus, which are the main causative agents
of (muco)cutaneous infections in the New World
including Colombia (4,5). This type of mapping and
analysis will form an important basis for phenotype-
based investigations of the Leishmania proteome.
Materials and methods
Chemicals
Acrylamide, bis-acrylamide, Coomassie blue R-
250 and ServalyteTM ampholytes for isoelectric
focusing were purchased from Serva GmbH
(Heidelberg, Germany). CarbamalyteTM isoelectric
point (pI) standards and broad range molecular
weight (M
r
) standards were obtained from
Amersham-Pharmacia Biotech (Uppsala, Sweden)
and  Bio-Rad (USA), respectively. All other re-
agents were of electrophoresis grade.
Biological material
Promastigotes of Leishmania (Viannia) guyanensis
(WHI/BT/78/M5313) including genetically-distinct
clones with highly-metastatic or non-metastatic
phenotypes (6,7) and L. (V.) panamensis (MHOM/
CO/86/1166) were cultured at 26 oC in Schneider´s
Drosophila medium containing 10% heat-
inactivated foetal bovine serum (Vecol, Bogotá,
Colombia), 1% glutamine, 100 U/ml penicillin and
100 µg/ml streptomycin.
Logarithmic phase parasites were harvested at 72
h after subculture by centrifugation (3,000 x g, 10
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min), washed in cold phosphate-buffered saline
(PBS; 13.6 mM NaCl, 0.27 mM KCl, 0.15 mM
KH2PO4, 0.4 mM Na2HPO4, pH 7.4) and either
solubilized immediately or stored at  -70 oC until
required.
Preparation of Leishmania protein extracts
Protein extracts of promastigotes were routinely
prepared by solubilizing108 parasites in 100 µl of
a buffer comprising 9 M urea, 4% Nonidet P-40
(NP-40) detergent, 2% 2-mercaptoethanol (2-ME)
and 5% of ServalyteTM ampholytes pH 9-11 (8, 9);
solubilization was assisted by passaging the
extract two to three times through a 21.5 gauge
needle using a Hamilton syringe. We have
previously demonstrated that this methodology
provides optimal representation and resolution of
Leishmania proteins on 2DE gels compared to
other protocols (9).
Following solubilization, samples were centrifuged
(14,000 x g, 2 min) to remove residual insoluble
material. The protein concentration of the final
soluble extract was determined using a
modification of the Bradford protein assay (10) to
enable standardization of sample loading on 2DE
gels.
Protein separation by 2DE. Solubilized proteins
were separated according to isoelectric point (pI)
in the first dimension by isoelectric focusing (IEF),
and subsequently by subunit molecular weight (M
r
)
using sodium dodecylsulphate polyacrylamide gel
electrophoresis (SDS-PAGE) in the second
dimension. IEF and SDS-PAGE were performed
using the IsoDalt 2DE system (Argonne National
Laboratory, Illinois, USA) (11,12).
The IsoDalt system enables protein samples to
be analysed simultaneously in multiples of 20
under identical electrophoretic conditions thus
ensuring reproducibility and comparability of
proteome maps. General procedures for the
preparation and electrophoresis of first- and
second-dimension gels using the IsoDalt were
essentially as described (11,12).
First dimension (IEF). Polyacrylamide IEF tube
gels (22 cm x 1.5 mm) were prepared containing
an equal mixture (50:50) of pH 5-7 and pH 3-10
carrier ampholytes (ServalyteTM) in order to give
optimal separation and resolution of proteins in
the neutral range (pH 5-7) using 10 mM phosphoric
acid as the anodal electrolyte and 20 mM sodium
hydroxide as the cathodal electrolyte. Pre-focusing
of the gels (at 200 V for 1 h) was performed to
establish the linear pH gradient via migration of
the ampholytes to their pI. The pH gradients of
IEF gels were calibrated by the addition of
CarbamalyteTM carbamylated protein standards of
known pI to selected Leishmania samples prior to
IEF (13). IEF gels were loaded with Leishmania
samples containing 350 µg of total protein for
Coomassie Blue staining or 100 mg of protein for
silver staining. Individual proteins were
subsequently focused to their pI by
electrophoresis at 800 V for 17.5 h (a total of 14,000
Volt-hours). Focused gels were equilibrated (in 125
mM Tris–HCl pH 6.8, containing 10% glycerol, 2%
SDS and 1% 2-ME), and then either transferred
directly to SDS-PAGE gels or stored at -70 oC until
used.
Second dimension (SDS-PAGE). IEF gels were
loaded onto 16 x 18 cm vertical polyacrylamide
slab gels (comprising a 9-18% acrylamide gradient)
and protein subunits were separated by
electrophoresis at 600 mA for 20 h (10) in SDS
running buffer (25 mM Tris base, 0.2 M glycine,





Protein profiles were revealed by post-
electrophoretic staining of SDS-PAGE gels with
protein dye reagents. Standard methods (14,15)
were employed for staining with silver nitrate.
Coomassie blue staining was achieved essentially
as described (16), except for the use of modified
staining reagent (0.25% Coomassie Blue R-250,
50% methanol, and 4% phosphoric acid)  which
gave optimal resolution of Leishmania proteins.
Destaining of gels was achieved using successive
30 min washes in 20% ethanol, until optimal
reduction of background staining was achieved.
Digital images of the protein maps were recorded
using the GelDoc 2000 gel documentation system
and associated software (BioRad).
Proteome map analysis. Comparative analysis of
digitized proteome maps was performed using the
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image analysis software Melanie III (version 3.08,
Geneva Bioinformatics S.A.; http://www.expasy.
ch/melanie/) (17). A minimum of five proteome
images for each Leishmania species or clone were
aligned and matched to generate a composite map
image.Landmark proteins were located and
annotated, and gel images were calibrated with
respect to pI and M
r
, enabling determination of
the physical parameters of proteins of interest.
Significant differences between protein patterns
and spot intensities (i.e., differentially expressed
proteins) were determined by pairwise
comparisons of spots between gel images.
Additional quantitation of differential spot
intensities was performed by densitometric
analysis using  Melanie III and Quantity One
software (BioRad) (results not shown).
Mass spectrometry and bioinformatics. Biological
mass spectrometry was employed (at the
University of Lausanne) to identify well-expressed
landmark proteins, which provide key reference
points within the Leishmania proteome map.
Individual protein spots (1.5 mm in diameter) were
excised directly from Coomassie blue-stained
SDS-PAGE gels. Proteins were then digested in
gel with trypsin essentially as described (18),
except that digestion was performed in 96 well
plates using a total 20 µg trypsin (Promega) per
plate and a ProGEST robotic system (Genomics
Solutions, Ann Arbor, Michigan). Peptide products
were recovered from the supernatant of tryptic
digests and analysed by liquid chromatography-
electrospray tandem mass spectrometry (LC-ES-
MS/MS) using a SCIEX QSTAR Pulsar hybrid
quadropole time-of-flight (Q-ToF) instrument
(Concord, Ontario, Canada), equipped with a
nanoelectrospray source and interfaced with a LC-
Packings Ultimate HPLC system (Amsterdam,
Holland). Separation of peptides was performed
using a PepMap reversed-phase capillary C18
column (75 mm internal diameter x 15 cm length)
at a flow rate of 200 nl/min along a 52 min gradient
of acetonitrile (0-40%). Peak detection and
selection of sequentially eluting peptides for
collision-induced fragmentation was controlled
using instrument-associated software.
Uninterpreted peptide mass spectra data were
used for direct interrogation of the MSDB or NCBInr
protein sequence databases using Mascot
software (www.matrixscience.com). Where direct
database searches failed to yield statistically
significant matches, the MS/MS spectra were
manually interpreted to derive sequence tags (of
5 to 10 amino acids in length) for each protein.
These sequence tags were then combined into a
unique search string and used for error tolerant
homology searches in the NCBInr database with
the MS-BLAST algorithm(http://dove.embl-
heidelberg.de/Blast2/msblast.html) (19).
Associated homology searches and bioinformatics
analyses were performed using the SwissProt/
(Tr)EMBL database of the Swiss Institute of
Bioinformatics and the European Bioinformatics
Institute (EBI) (http://expasy.ch), the EBI genomic
database (http://www.ebi.ac.uk) and the
Leishmania major genomic and expression
sequence tag (EST) databases (http://
www.sanger.ac.uk).
Immunodetection. Immunoprobing of Leishmania
proteome maps was performed using monoclonal
antibody (mAb) 2E10 which recognizes
Leishmania paraflagellar rod proteins 1 and 2 (PFR-
1/-2), and was generously provided by Dr. Diane
McMahon-Pratt (20). Two dimensional protein
arrays were transferred from SDS-PAGE gels to
PVDF transfer membrane Hybond-P (Amersham-
Pharmacia Biotech) by electroblotting at 100 V
for 1.5 h. Membranes were subsequently incubated
overnight at 4 oC in blocking buffer (PBS containing
5% BSA, 0.2% horse serum, and 0.3% Tween-
20), washed twice (5 min, 25 oC) in wash buffer
(PBS/0.05% Tween), and then incubated (1 h, 25
oC) with mAb 2E10 at a dilution of 1:500 in wash
buffer. Following two further washes (as above),
blots were incubated (30 min, 25 oC) with universal
peroxidase-labeled secondary antibody (DAKO
Corporation, California), washed twice (as above)
and then immunoreactive spots were visualized
colourimetrically by incubating blots in 3,3’-
diaminobenzidine substrate for peroxidase (Vector
Laboratories, California) according to
manufacturer´s instructions.
Results
The described 2DE methodology yielded highly
reproducible proteome maps of the neutral pI range
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of soluble extracts of L. Viannia promastigotes with
good representation and resolution of protein spots
(figure 1a, 1b).
Approximately 800 protein spots were routinely
detected using Coomassie blue staining and 1,500
spots using silver nitrate, thereby verifying the
advantageous greater sensitivity of the latter
method (14,15). Nevertheless, Coomassie blue is
known to produce staining intensities that are
proportional (within limits) to protein abundance,
whilst silver staining can give rise to
disproportionate intensities resulting in under- or
overestimation of protein quantity. This differential
staining of individual proteins results from
variations between the respective chemical
interactions of the two dye reagents with proteins,
although the latter have not been fully defined (21).
Additionally, silver stain reagent interferes
considerably with mass spectrometric analyses
(22), and so Coomassie blue-stained protein spots
were used exclusively for peptide sequencing via
mass spectrometry.
The strongly expressed reference proteins R1 to
R6 were consistently observed in all maps of both
Leishmania strains investigated, and were isolated
and identified by mass spectrometry and
Figures 1a and 1b. Reference soluble proteome maps (pH 5-7) of promastigotes of a) L. guyanensis and b) L. panamensis
showing landmark proteins identified by mass spectrometry. Soluble proteome maps of promastigotes were produced by
IEF (with amplification of the neutral region pH 5-7) in the first dimension and 9%-18% gradient SDS-PAGE in the second
dimension followed by protein staining with a) Coomassie blue and b) silver nitrate, respectively (see Materials and methods).
The identities of reference proteins R1-R6 are presented in table 1.
bioinformatics analyses in order to establish land-
marks for the proteome.
Consistent data was obtained via mass
spectrometric sequencing of peptides derived from
multiple samples of the R1 to R6 protein spots.
Peptide sequences generated from each
reference protein by LC-ES-MS/MS displayed
high amino acid identities with specific database
sequences of proteins from other Leishmania
species, allowing unequivocal identification of
R1 to R6 as members of the heat shock protein
family, kinetoplast membrane protein-11,
ribosomal protein S12 and a hypothetical,
Leishmania-specific 13 kDa protein of unknown
function (table 1).
The capacity of 2DE to capture variations in
protein expression profile is illustrated in figure 2,
which shows marked differences in the expression
profiles of four proteins (designated α, β, γ and δ)
in the soluble proteomes of two genetically distinct
L. guyanensis clones with differing metastatic
capacities.
The power of immunoblotting as a tool for protein
identification in proteome maps was demonstrated
by the specific detection of the L. guyanensis PFR-
1 and PFR-2 proteins using mAb 2E10 (figure 3).
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Table 1. Identities and physical properties of reference proteins R1 to R6 of L. guyanenesis promastigotes.
Protein Identity a Accession No. of No. of matching Physico-chemical properties
code homologue peptides                               subunit M
r
 (Species)b (kDa) c pI d
R1 Heat shock protein SwissProt P12077 4 76.3 ± 3.5   (5) 5.4 ± 0.07 (5)
70 kDa (4) (L. major)
R2 Heat shock protein SwissProt P12076 3 73.1 ± 4.3  (5) 6.1 ± 0.07 (5)
70 kDa (1) (L. major)
R3 Heat shock protein (Tr)EMBL O61118 7 66.0 ± 2.4  (5) 5.7 ± 0.07 (5)
60 kDa (L. brasiliensis)
(Chaperonin)
R4 Ribosomal protein (Tr)EMBL Q9GRJ6 4 18.1 ± 1.0   (5) 5.2 ± 0.05 (5)
S12 (L. major)
R5 Hypothetical protein (Tr)EMBL Q9BLU8 1 15.1 ± 0.7   (5) 4.9 ± 0.02 (5)
(13 kDa) (L. major)
R6 Kinetoplast membrane protein (Tr)EMBL O43974 1 12.9 ± 1.0   (5) 6.3 ± 0.04 (5)
11 (L. brasiliensis)
a Proteins identified by mass spectrometry and bioinformatics analyses (see Materials and methods).
b Database accession numbers are indicated for homologous proteins/genes from other Leishmania species.
c Subunit M
r
s were determined via relative mobility calculations using standard marker proteins (BioRad). Data are
presented as mean M
r 
± S.D., with number of replicate 2DE gels in parentheses.
d pI values were determined by calculating the mobilities of proteins relative to a series of carbamylated creatine
phosphokinase standards (11). Data are presented as pI
 
± SD, with number of replicate 2DE gels in parentheses.
Figure  2. Detection of differential protein expression in genetically-distinct laboratory clones of L. guyanensis. Panels A
and B show the same amplified regions of Coomassie blue stained soluble proteome maps (pH 5-7) of two distinct L.
guyanensis laboratory clones, highlighting the differential expression of proteins α, β, γ and δ.
The physico-chemical properties of the
immunoreactive protein spots (subunit M
rs
 of 77.5
and 81.4 kDa, and pIs of 5.93 and 6.02,
respectively) correlated extremely well with those
reported  previously for the subunits of PFR-1 and
PFR-2 (20).
Comparative analyses of spot coordinates were
used to determine the location of the
corresponding PFR-1 and PFR-2 spots in
Coomassie blue-stained proteome maps produced
in parallel with the immunoblot (figure 3). (The
accuracy of localization of the PFR-2 spot was
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Figure 3. Specific immunodetection of paraflagellar rod proteins 1 and 2 in the proteome map of L. guyanenesis. Immunoblot
analysis of the soluble (pH 5-7) proteome of L. guyanensis promastigotes using mAb 2E10 was performed as described
in Materials and methods. Panel A shows the immunoreactive subunits of PFR-1 (M
r 
81.4 ± 0.7 kDa; pI 6.02 ± 0.03, n=3)
and PFR-2 (M
r 
77.5 ± 0.7 kDa;  pI 5.93 ± 0.01, n=3), and panel B shows the corresponding region of a Coomassie blue-
stained proteome map with the identified PFR-1 and 2 subunits arrowed.
subsequently confirmed by 2DE analysis of L.
guyanensis extracts containing samples of pure
recombinant PFR-2 protein, and the specificity of
mAb 2E10 was also confirmed by one-dimensional
SDS-PAGE and immunoblotting of promastigote
extracts; data not shown).
Discussion
The successful production of reference proteome
maps, identification of selected protein spots by
mass spectrometry/bioinformatics and immuno-
detection, and capacity to detect differentially
expressed proteins collectively confirm the utility
of proteomics as a tool for phenotypic analyses
of Leishmania parasites.
Although suitable for detailed expression analyses
of high- and medium-abundance proteins, these
baseline proteome maps are not entirely
representative since numerous low-abundance
proteins are not detected by Coomassie blue or
even silver staining; this is a common limitation
when performing whole proteome analysis by 2DE.
Another limitation is the high density of spots in
the pH 5-7 region, which inevitably leads to a degree
of overlapping of certain adjacent protein spots.
However, the representation and resolution of
protein spots will be improved further by the use
of recently developed fluorescent protein stains
(such as SYPRO Orange or Ruby) which offer
higher sensitivity (with a lower limit of detection
of 50 fmol of protein).
Furthermore, the complexity of the proteins in
parasite extracts can be reduced via use of narrow
range pH and acrylamide gradients in the first and
second dimensions, respectively, and/or
fractionation of protein samples prior to 2DE.
These modifications enable the amplification of
specific regions of the proteome for more detailed
analyses.
Leishmania is particularly amenable to proteomics-
based studies due to its relatively small genome
size: the Leishmania major genome is currently
estimated to contain a maximum of  9,800 genes
(23). Significantly, the proteins encoded by the
majority (69%) of L. major genes sequenced to
date remain unclassified with respect to putative
biological function, and around 40% of these are
potentially unique to Leishmania (23).
Proteomics will play an increasingly important role
in linking genomics with functional analyses of
both classified and unclassified Leishmania gene
products, especially in relation to the molecular
mechanisms of parasite virulence and drug
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resistance, the identification of drug targets and
vaccine antigens, and the analysis of host-para-
site interactions.
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